{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:40:30Z","timestamp":1792276830880,"version":"4.4.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2048260"],"award-info":[{"award-number":["2048260"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2020633"],"award-info":[{"award-number":["2020633"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Despite viral suppression with antiretroviral therapy, people with HIV (PWH) remain at increased risk of neurocognitive impairment, neuroinflammation, and potential viral rebound following therapy interruption. Although the central nervous system (CNS) is a recognised HIV reservoir, it is often not fully considered in cure approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>HIV DNA and ongoing viral transcription persist in the CNS of ART-suppressed PWH, potentially contributing to neuroinflammation and neurocognitive dysfunction. HIV cure strategies, including latency-reversing\/promoting agents, broadly neutralising antibodies and other approaches have varying degrees of CNS penetration, efficacy and potential neurotoxicity. Therefore, interventions aimed at silencing or eradicating HIV reservoirs require monitoring of both reservoir-targeting efficacy and neurological adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Greater consideration of CNS penetration, efficacy in targeting CNS reservoirs, and neurotoxicity is required in HIV cure studies. Developing CNS-inclusive strategies that minimise adverse neurological effects may be an important step in achieving HIV cure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11904-026-00798-9","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:02:14Z","timestamp":1792234934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Central Nervous System Reservoirs and HIV Cure: Therapeutic Opportunities and Challenges"],"prefix":"10.1007","volume":"23","author":[{"given":"Thomas A.","family":"Angelovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Gorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"798_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S2055-6640(20)30489-1","volume":"1","author":"J Hellmuth","year":"2015","unstructured":"Hellmuth J, Valcour V, Spudich S. CNS reservoirs for HIV: implications for eradication. J Virus Erad. 2015;1:67\u201371.","journal-title":"J Virus Erad"},{"key":"798_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/cid\/ciu862","volume":"60","author":"RK Heaton","year":"2015","unstructured":"Heaton RK, Franklin DR Jr., Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015;60:473\u201380.","journal-title":"Clin Infect Dis"},{"key":"798_CR3","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/cid\/cix998","volume":"66","author":"C Wong","year":"2018","unstructured":"Wong C, Gange SJ, Moore RD, Justice AC, Buchacz K, Abraham AG, Rebeiro PF, Koethe JR, Martin JN, Horberg MA, et al. Multimorbidity among persons living with human immunodeficiency virus in the United States. Clin Infect Dis. 2018;66:1230\u20138.","journal-title":"Clin Infect Dis"},{"key":"798_CR4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, Longenecker CT, Strachan F, Bagchi S, Whiteley W, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138:1100\u201312.","journal-title":"Circulation"},{"key":"798_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s11904-022-00628-8","volume":"19","author":"PK Riggs","year":"2022","unstructured":"Riggs PK, Chaillon A, Jiang G, Letendre SL, Tang Y, Taylor J, Kaytes A, Smith DM, Dub\u00e9 K, Gianella S. Lessons for understanding central nervous system HIV reservoirs from the Last Gift Program. Curr HIV\/AIDS Rep. 2022;19:566\u201379.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"798_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/v17040467","volume":"17","author":"MM N\u00fchn","year":"2025","unstructured":"N\u00fchn MM, Gumbs SBH, Schipper PJ, Drosou I, Gharu L, Buchholtz N, Snijders G, Gigase FAJ, Wensing AMJ, Symons J, et al. Microglia exhibit a unique intact HIV reservoir in human postmortem brain tissue. Viruses. 2025;17:467.","journal-title":"Viruses"},{"key":"798_CR7","doi-asserted-by":"publisher","first-page":"e167417","DOI":"10.1172\/JCI167417","volume":"133","author":"Y Tang","year":"2023","unstructured":"Tang Y, Chaillon A, Gianella S, Wong LM, Li D, Simermeyer TL, Porrachia M, Ignacio C, Woodworth B, Zhong D, et al. Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy. J Clin Invest. 2023;133:e167417.","journal-title":"J Clin Invest"},{"key":"798_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-023-00616-9","volume":"20","author":"A Wahl","year":"2023","unstructured":"Wahl A, Al-Harthi L. HIV infection of non-classical cells in the brain. Retrovirology. 2023;20:1.","journal-title":"Retrovirology"},{"key":"798_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/COH.0000000000000847","volume":"19","author":"A Mastrangelo","year":"2024","unstructured":"Mastrangelo A, Gama L, Cinque P. Strategies to target the central nervous system HIV reservoir. Curr Opin HIV AIDS. 2024;19:133\u201340.","journal-title":"Curr Opin HIV AIDS"},{"key":"798_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/ana.26750","volume":"94","author":"TA Angelovich","year":"2023","unstructured":"Angelovich TA, Cochrane CR, Zhou J, Tumpach C, Byrnes SJ, Jamal Eddine J, Waring E, Busman-Sahay K, Deleage C, Jenkins TA, et al. Regional analysis of intact and defective HIV proviruses in the brain of viremic and virally suppressed people with HIV. Ann Neurol. 2023;94:798\u2013802.","journal-title":"Ann Neurol"},{"key":"798_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11904-026-00790-3","volume":"23","author":"TA Angelovich","year":"2026","unstructured":"Angelovich TA, Jamal Eddine J, Chalmers EK, Byrnes SJ, Churchill MJ. HIV Reservoirs in brain parenchyma and cerebrospinal fluid during suppressive ART: same-same or very different? Curr HIV\/AIDS Rep. 2026;23:19.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"798_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/v15041009","volume":"15","author":"D Gabuzda","year":"2023","unstructured":"Gabuzda D, Yin J, Misra V, Chettimada S, Gelman BB. Intact proviral DNA analysis of the brain viral reservoir and relationship to neuroinflammation in people with HIV on suppressive antiretroviral therapy. Viruses. 2023;15:1009.","journal-title":"Viruses"},{"key":"798_CR13","doi-asserted-by":"publisher","first-page":"e0054323","DOI":"10.1128\/jvi.00543-23","volume":"97","author":"MF Oliveira","year":"2023","unstructured":"Oliveira MF, Pankow A, Vollbrecht T, Kumar NM, Cabalero G, Ignacio C, Zhao M, Vitomirov A, Gouaux B, Nakawawa M, et al. Evaluation of archival HIV DNA in brain and lymphoid tissues. J Virol. 2023;97:e0054323.","journal-title":"J Virol"},{"key":"798_CR14","doi-asserted-by":"publisher","first-page":"e1014446","DOI":"10.1371\/journal.ppat.1014446","volume":"22","author":"RS Dave","year":"2026","unstructured":"Dave RS, Oludipe AA, Pasipanodya EC, Sherman S, Wilson SH, Gabuzda DH, Churchill MJ, Angelovich TA, Gorelick RJ, Gianella S, et al. The brain as an HIV reservoir: recent findings using autopsy tissues from people with HIV. PLoS Pathog. 2026;22:e1014446.","journal-title":"PLoS Pathog"},{"key":"798_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.26456","volume":"92","author":"CR Cochrane","year":"2022","unstructured":"Cochrane CR, Angelovich TA, Byrnes SJ, Waring E, Guanizo AC, Trollope GS, Zhou J, Vue J, Senior L, Wanicek E, et al. Intact HIV proviruses persist in the brain despite viral suppression with ART. Ann Neurol. 2022;92:532\u201344.","journal-title":"Ann Neurol"},{"key":"798_CR16","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.3390\/cells11152379","volume":"11","author":"M Donoso","year":"2022","unstructured":"Donoso M, D\u2019Amico D, Valdebenito S, Hernandez CA, Prideaux B, Eugenin EA. Identification, quantification, and characterization of HIV-1 reservoirs in the human brain. Cells. 2022;11:2379.","journal-title":"Cells"},{"key":"798_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/brain\/awy339","volume":"142","author":"L Bertrand","year":"2019","unstructured":"Bertrand L, Cho HJ, Toborek M. Blood-brain barrier pericytes as a target for HIV-1 infection. Brain. 2019;142:502\u201311.","journal-title":"Brain"},{"key":"798_CR18","doi-asserted-by":"crossref","unstructured":"Cai Y-Y, Jacobs N, Gabuzda DH, Corley MJ, Herb BR, Volsky DJ, Receveur JP, Matkhanov D, White OR, Spudich S et al. Sensitive detection of rare HIV-infected cells in the human brain by single-nucleus RNA sequencing. Virology Journal. 2026:In press.","DOI":"10.1186\/s12985-026-03285-0"},{"key":"798_CR19","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1172\/JCI134815","volume":"130","author":"A Chaillon","year":"2020","unstructured":"Chaillon A, Gianella S, Dellicour S, Rawlings SA, Schlub TE, De Oliveira MF, Ignacio C, Porrachia M, Vrancken B, Smith DM. HIV persists throughout deep tissues with repopulation from multiple anatomical sources. J Clin Invest. 2020;130:1699\u2013712.","journal-title":"J Clin Invest"},{"key":"798_CR20","doi-asserted-by":"publisher","first-page":"e2012191118","DOI":"10.1073\/pnas.2012191118","volume":"118","author":"Y Lu","year":"2021","unstructured":"Lu Y, Bohn-Wippert K, Pazerunas PJ, Moy JM, Singh H, Dar RD. Screening for gene expression fluctuations reveals latency-promoting agents of HIV. Proc Natl Acad Sci U S A. 2021;118:e2012191118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"798_CR21","doi-asserted-by":"publisher","first-page":"e2313823121","DOI":"10.1073\/pnas.2313823121","volume":"121","author":"A Blanco","year":"2024","unstructured":"Blanco A, Coronado RA, Arun N, Ma K, Dar RD, Kieffer C. Monocyte to macrophage differentiation and changes in cellular redox homeostasis promote cell type-specific HIV latency reactivation. Proc Natl Acad Sci. 2024;121:e2313823121.","journal-title":"Proc Natl Acad Sci"},{"key":"798_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","volume":"21","author":"RA Pollack","year":"2017","unstructured":"Pollack RA, Jones RB, Pertea M, Bruner KM, Martin AR, Thomas AS, Capoferri AA, Beg SA, Huang SH, Karandish S, et al. Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape. Cell Host Microbe. 2017;21:494\u2013e5064.","journal-title":"Cell Host Microbe"},{"key":"798_CR23","doi-asserted-by":"publisher","first-page":"RP89837","DOI":"10.7554\/eLife.89837.3","volume":"12","author":"W Sun","year":"2023","unstructured":"Sun W, Rassadkina Y, Gao C, Collens SI, Lian X, Solomon IH, Mukerji S, Yu XG, Lichterfeld M. Persistence of intact HIV-1 proviruses in the brain during suppressive antiretroviral therapy. Elife. 2023;12:RP89837.","journal-title":"Elife"},{"key":"798_CR24","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1073\/pnas.1609057113","volume":"113","author":"H Imamichi","year":"2016","unstructured":"Imamichi H, Dewar RL, Adelsberger JW, Rehm CA, O\u2019Doherty U, Paxinos EE, Fauci AS, Lane HC. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc Natl Acad Sci U S A. 2016;113:8783\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"798_CR25","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1073\/pnas.1917876117","volume":"117","author":"H Imamichi","year":"2020","unstructured":"Imamichi H, Smith M, Adelsberger JW, Izumi T, Scrimieri F, Sherman BT, Rehm CA, Imamichi T, Pau A, Catalfamo M, et al. Defective HIV-1 proviruses produce viral proteins. Proc Natl Acad Sci U S A. 2020;117:3704\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"798_CR26","doi-asserted-by":"publisher","first-page":"e1012446","DOI":"10.1371\/journal.ppat.1012446","volume":"20","author":"J Jamal Eddine","year":"2024","unstructured":"Jamal Eddine J, Angelovich TA, Zhou J, Byrnes SJ, Tumpach C, Saraya N, Chalmers E, Shepherd RA, Tan A, Marinis S, et al. HIV transcription persists in the brain of virally suppressed people with HIV. PLoS Pathog. 2024;20:e1012446.","journal-title":"PLoS Pathog"},{"key":"798_CR27","doi-asserted-by":"publisher","first-page":"e1009982","DOI":"10.1371\/journal.ppat.1009982","volume":"17","author":"J Kuniholm","year":"2021","unstructured":"Kuniholm J, Armstrong E, Bernabe B, Coote C, Berenson A, Patalano SD, Olson A, He X, Lin NH, Fuxman Bass JI, et al. Intragenic proviral elements support transcription of defective HIV-1 proviruses. PLoS Pathog. 2021;17:e1009982.","journal-title":"PLoS Pathog"},{"key":"798_CR28","first-page":"e00552","volume":"0","author":"M Kilroy Jonathan","year":"2026","unstructured":"Kilroy Jonathan M, Deokar Aparna A, Patalano S, Fuxman Bass Juan I, Sagar M, Gummuluru S, Henderson Andrew J. Intragenic transcription from defective HIV proviruses triggers interferon responses in myeloid cells. J Virol. 2026;0:e00552\u201326.","journal-title":"J Virol"},{"key":"798_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41467-022-28727-5","volume":"13","author":"DR Beckford-Vera","year":"2022","unstructured":"Beckford-Vera DR, Flavell RR, Seo Y, Martinez-Ortiz E, Aslam M, Thanh C, Fehrman E, Pardons M, Kumar S, Deitchman AN, et al. First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody. Nat Commun. 2022;13:1219.","journal-title":"Nat Commun"},{"key":"798_CR30","unstructured":"M P, S N, L G. Infiltration of bNAB VRC01 into the cerebrospinal fluid in humans in the RV397 study. CROI 2020, Boston, USA Conference abstract 453 2020."},{"key":"798_CR31","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/infdis\/jiac138","volume":"226","author":"M Spatola","year":"2022","unstructured":"Spatola M, Loos C, Cizmeci D, Webb N, Gorman MJ, Rossignol E, Shin S, Yuan D, Fontana L, Mukerji SS, et al. Functional compartmentalization of antibodies in the central nervous system during chronic HIV infection. J Infect Dis. 2022;226:738\u201350.","journal-title":"J Infect Dis"},{"key":"798_CR32","doi-asserted-by":"publisher","first-page":"e1009738","DOI":"10.1371\/journal.ppat.1009738","volume":"17","author":"J Wen","year":"2021","unstructured":"Wen J, Cheever T, Wang L, Wu D, Reed J, Mascola J, Chen X, Liu C, Pegu A, Sacha JB, et al. Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques. PLoS Pathog. 2021;17:e1009738.","journal-title":"PLoS Pathog"},{"key":"798_CR33","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1021\/acsnano.5c19138","volume":"20","author":"EL Han","year":"2026","unstructured":"Han EL, Kim D, Murray AM, Mrksich K, Hamilton AG, Tang S, Yoo S, Zhu AT, Tong ER, Palanki R, et al. High-throughput in vivo screening identifies structural factors driving mRNA lipid nanoparticle delivery to the brain. ACS Nano. 2026;20:3807\u201320.","journal-title":"ACS Nano"},{"key":"798_CR34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","volume":"25","author":"EL Han","year":"2025","unstructured":"Han EL, Tang S, Kim D, Murray AM, Swingle KL, Hamilton AG, Mrksich K, Padilla MS, Palanki R, Li JJ, et al. Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain. Nano Lett. 2025;25:800\u201310.","journal-title":"Nano Lett"},{"key":"798_CR35","doi-asserted-by":"publisher","first-page":"116737","DOI":"10.1016\/j.biopha.2024.116737","volume":"175","author":"YQ Yeoh","year":"2024","unstructured":"Yeoh YQ, Amin A, Cuic B, Tomas D, Turner BJ, Shabanpoor F. Efficient systemic CNS delivery of a therapeutic antisense oligonucleotide with a blood-brain barrier-penetrating ApoE-derived peptide. Biomed Pharmacother. 2024;175:116737.","journal-title":"Biomed Pharmacother"},{"key":"798_CR36","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1038\/s41467-023-38582-7","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen X, Wolfe DA, Bindu DS, Zhang M, Taskin N, Goertsen D, Shay TF, Sullivan EE, Huang SF, Ravindra Kumar S, et al. Functional gene delivery to and across brain vasculature of systemic AAVs with endothelial-specific tropism in rodents and broad tropism in primates. Nat Commun. 2023;14:3345.","journal-title":"Nat Commun"},{"key":"798_CR37","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1016\/j.ymthe.2025.04.046","volume":"33","author":"TC Moyer","year":"2025","unstructured":"Moyer TC, Hoffman BA, Chen W, Shah I, Ren X-Q, Knox T, Liu J, Wang W, Li J, Khalid H, et al. Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier. Mol Ther. 2025;33:3902\u201316.","journal-title":"Mol Ther"},{"key":"798_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.chembiol.2023.09.008","volume":"31","author":"G Pornnoppadol","year":"2024","unstructured":"Pornnoppadol G, Bond LG, Lucas MJ, Zupancic JM, Kuo Y-H, Zhang B, Greineder CF, Tessier PM. Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs. Cell Chem Biology. 2024;31:361\u2013e728.","journal-title":"Cell Chem Biology"},{"key":"798_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41434-023-00410-4","volume":"31","author":"TH Burdo","year":"2024","unstructured":"Burdo TH, Chen C, Kaminski R, Sariyer IK, Mancuso P, Donadoni M, Smith MD, Sariyer R, Caocci M, Liao S, et al. Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates. Gene Ther. 2024;31:224\u201333.","journal-title":"Gene Ther"},{"key":"798_CR40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12974-017-1019-y","volume":"14","author":"A Proust","year":"2017","unstructured":"Proust A, Barat C, Leboeuf M, Drouin J, Tremblay MJ. Contrasting effect of the latency-reversing agents bryostatin-1 and JQ1 on astrocyte-mediated neuroinflammation and brain neutrophil invasion. J Neuroinflammation. 2017;14:242.","journal-title":"J Neuroinflammation"},{"key":"798_CR41","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.4049\/jimmunol.1600742","volume":"198","author":"C Dental","year":"2017","unstructured":"Dental C, Proust A, Ouellet M, Barat C, Tremblay MJ. HIV-1 Latency-reversing agents prostratin and bryostatin-1 induce blood-brain barrier disruption\/inflammation and modulate leukocyte adhesion\/transmigration. J Immunol. 2017;198:1229\u201341.","journal-title":"J Immunol"},{"issue":"Suppl 2","key":"798_CR42","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1097\/00126334-200210012-00005","volume":"31","author":"NJ Haughey","year":"2002","unstructured":"Haughey NJ, Mattson MP. Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J Acquir Immune Defic Syndr. 2002;31(Suppl 2):S55\u201361.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"798_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s13365-015-0413-4","volume":"22","author":"LR Gray","year":"2016","unstructured":"Gray LR, On H, Roberts E, Lu HK, Moso MA, Raison JA, Papaioannou C, Cheng WJ, Ellett AM, Jacobson JC, et al. Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells. J Neurovirol. 2016;22:455\u201363.","journal-title":"J Neurovirol"},{"key":"798_CR44","doi-asserted-by":"publisher","first-page":"e1885","DOI":"10.1093\/cid\/ciaa1344","volume":"73","author":"J Hellmuth","year":"2021","unstructured":"Hellmuth J, Muccini C, Colby DJ, Kroon E, de Souza M, Crowell TA, Chan P, Sacdalan C, Intasan J, Benjapornpong K, et al. Central nervous system safety during brief analytic treatment interruption of antiretroviral therapy within 4 human immunodeficiency virus remission trials: an observational study in acutely treated people living with human immunodeficiency virus. Clin Infect Dis. 2021;73:e1885\u201392.","journal-title":"Clin Infect Dis"},{"key":"798_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/QAD.0000000000003091","volume":"36","author":"JH McMahon","year":"2022","unstructured":"McMahon JH, Evans VA, Lau JSY, Symons J, Zerbato JM, Chang J, Solomon A, Tennakoon S, Dantanarayana A, Hagenauer M, et al. Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal. Aids. 2022;36:75\u201382.","journal-title":"Aids"},{"key":"798_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12974-019-1565-6","volume":"16","author":"C Gavegnano","year":"2019","unstructured":"Gavegnano C, Haile WB, Hurwitz S, Tao S, Jiang Y, Schinazi RF, Tyor WR. Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro. J Neuroinflammation. 2019;16:182.","journal-title":"J Neuroinflammation"},{"key":"798_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/cid\/ciab212","volume":"74","author":"VC Marconi","year":"2022","unstructured":"Marconi VC, Moser C, Gavegnano C, Deeks SG, Lederman MM, Overton ET, Tsibris A, Hunt PW, Kantor A, Sekaly RP, et al. Randomized trial of ruxolitinib in antiretroviral-treated adults with human immunodeficiency virus. Clin Infect Dis. 2022;74:95\u2013104.","journal-title":"Clin Infect Dis"},{"key":"798_CR48","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1212\/WNL.0000000000215615","volume":"106","author":"W Tyor","year":"2026","unstructured":"Tyor W, Siegel K, Malone K, Xu B, Bromley J, Loring D, Gupta S, Harrison T, Nguyen M, Peterson R, et al. A placebo controlled trial of baricitinib in people on ART to reduce CNS HIV (P1-3.003). Neurology. 2026;106:2122.","journal-title":"Neurology"},{"key":"798_CR49","doi-asserted-by":"publisher","first-page":"e1010110","DOI":"10.1371\/journal.ppat.1010110","volume":"18","author":"F Ye","year":"2022","unstructured":"Ye F, Alvarez-Carbonell D, Nguyen K, Leskov K, Garcia-Mesa Y, Sreeram S, Valadkhan S, Karn J. Recruitment of the CoREST transcription repressor complexes by nerve growth factor IB-like receptor (Nurr1\/NR4A2) mediates silencing of HIV in microglial cells. PLoS Pathog. 2022;18:e1010110.","journal-title":"PLoS Pathog"},{"key":"798_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","volume":"23","author":"Y Kim","year":"2018","unstructured":"Kim Y, Anderson JL, Lewin SR. Getting the kill into shock and kill: strategies to eliminate latent HIV. Cell Host Microbe. 2018;23:14\u201326.","journal-title":"Cell Host Microbe"},{"key":"798_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12977-017-0335-8","volume":"14","author":"D Alvarez-Carbonell","year":"2017","unstructured":"Alvarez-Carbonell D, Garcia-Mesa Y, Milne S, Das B, Dobrowolski C, Rojas R, Karn J. Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells. Retrovirology. 2017;14:9.","journal-title":"Retrovirology"},{"key":"798_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s13365-017-0604-2","volume":"24","author":"GN Llewellyn","year":"2018","unstructured":"Llewellyn GN, Alvarez-Carbonell D, Chateau M, Karn J, Cannon PM. HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency. J Neurovirol. 2018;24:192\u2013203.","journal-title":"J Neurovirol"},{"key":"798_CR53","doi-asserted-by":"publisher","first-page":"eaec0149","DOI":"10.1126\/sciadv.aec0149","volume":"12","author":"X Li","year":"2026","unstructured":"Li X, Li D, Tang Y, Nearing M, Varco-Merth B, Chen H, Smith D, Gianella S, Archin NM, Okoye AA, et al. Histone decrotonylation plays a distinct role in HIV latency. Sci Adv. 2026;12:eaec0149.","journal-title":"Sci Adv"},{"key":"798_CR54","doi-asserted-by":"publisher","first-page":"e1008249","DOI":"10.1371\/journal.ppat.1008249","volume":"15","author":"D Alvarez-Carbonell","year":"2019","unstructured":"Alvarez-Carbonell D, Ye F, Ramanath N, Garcia-Mesa Y, Knapp PE, Hauser KF, Karn J. Cross-talk between microglia and neurons regulates HIV latency. PLoS Pathog. 2019;15:e1008249.","journal-title":"PLoS Pathog"},{"key":"798_CR55","doi-asserted-by":"publisher","first-page":"e01563","DOI":"10.1128\/jvi.01563-19","volume":"94","author":"V Edara Venkata","year":"2020","unstructured":"Edara Venkata V, Ghorpade A, Borgmann K. Insights into the gene expression profiles of active and restricted red\/green-HIV+ human astrocytes: implications for shock or lock therapies in the brain. J Virol. 2020;94:e01563-19. https:\/\/doi.org\/10.1128\/jvi.01563-19.","journal-title":"J Virol"},{"key":"798_CR56","doi-asserted-by":"publisher","first-page":"e01880","DOI":"10.1128\/JVI.01880-19","volume":"94","author":"E Alamer","year":"2020","unstructured":"Alamer E, Zhong C, Liu Z, Niu Q, Long F, Guo L, Gelman BB, Soong L, Zhou J, Hu H. Epigenetic suppression of HIV in myeloid cells by the BRD4-selective small molecule modulator ZL0580. J Virol. 2020;94:e01880-19.","journal-title":"J Virol"},{"key":"798_CR57","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/v12101154","volume":"12","author":"A Olson","year":"2020","unstructured":"Olson A, Basukala B, Lee S, Gagne M, Wong WW, Henderson AJ. Targeted chromatinization and repression of HIV-1 provirus transcription with repurposed CRISPR\/Cas9. Viruses. 2020;12:1154.","journal-title":"Viruses"},{"key":"798_CR58","doi-asserted-by":"publisher","first-page":"e00465","DOI":"10.1128\/mBio.00465-15","volume":"6","author":"G Mousseau","year":"2015","unstructured":"Mousseau G, Kessing CF, Fromentin R, Trautmann L, Chomont N, Valente ST. The Tat Inhibitor didehydro-cortistatin A prevents HIV-1 reactivation from latency. mBio. 2015;6:e00465.","journal-title":"mBio"},{"key":"798_CR59","doi-asserted-by":"publisher","first-page":"e02662","DOI":"10.1128\/mBio.02662-18","volume":"10","author":"S Mediouni","year":"2019","unstructured":"Mediouni S, Chinthalapudi K, Ekka MK, Usui I, Jablonski JA, Clementz MA, Mousseau G, Nowak J, Macherla VR, Beverage JN, et al. Didehydro-Cortistatin A Inhibits HIV-1 by specifically binding to the unstructured basic region of tat. mBio. 2019;10:e02662-18.","journal-title":"mBio"},{"key":"798_CR60","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.celrep.2017.09.080","volume":"21","author":"CF Kessing","year":"2017","unstructured":"Kessing CF, Nixon CC, Li C, Tsai P, Takata H, Mousseau G, Ho PT, Honeycutt JB, Fallahi M, Trautmann L, et al. In vivo suppression of HIV rebound by Didehydro-Cortistatin A, a block-and-lock strategy for HIV-1 treatment. Cell Rep. 2017;21:600\u201311.","journal-title":"Cell Rep"},{"key":"798_CR61","doi-asserted-by":"publisher","first-page":"e0092323","DOI":"10.1128\/jvi.00923-23","volume":"97","author":"RM Horvath","year":"2023","unstructured":"Horvath RM, Brumme ZL, Sadowski I. CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells. J Virol. 2023;97:e0092323.","journal-title":"J Virol"},{"key":"798_CR62","doi-asserted-by":"publisher","first-page":"e01386","DOI":"10.1128\/JVI.01386-20","volume":"95","author":"H Akiyama","year":"2021","unstructured":"Akiyama H, Jalloh S, Park S, Lei M, Mostoslavsky G, Gummuluru S. Expression of HIV-1 Intron-containing RNA in microglia induces inflammatory responses. J Virol. 2021;95:e01386-20.","journal-title":"J Virol"},{"key":"798_CR63","doi-asserted-by":"publisher","first-page":"1570692","DOI":"10.3389\/fimmu.2025.1570692","volume":"16","author":"SJ Byrnes","year":"2025","unstructured":"Byrnes SJ, Jamal Eddine J, Zhou J, Chalmers E, Wanicek E, Osman N, Jenkins TA, Roche M, Brew BJ, Estes JD, et al. Neuroinflammation associated with proviral DNA persists in the brain of virally suppressed people with HIV. Front Immunol. 2025;16:1570692.","journal-title":"Front Immunol"},{"key":"798_CR64","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1111\/febs.14293","volume":"284","author":"LA Campbell","year":"2017","unstructured":"Campbell LA, Richie CT, Zhang Y, Heathward EJ, Coke LM, Park EY, Harvey BK. In vitro modeling of HIV proviral activity in microglia. Febs j. 2017;284:4096\u2013114.","journal-title":"Febs j"},{"key":"798_CR65","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrm4048","volume":"16","author":"BA Benayoun","year":"2015","unstructured":"Benayoun BA, Pollina EA, Brunet A. Epigenetic regulation of ageing: linking environmental inputs to genomic stability. Nat Rev Mol Cell Biol. 2015;16:593\u2013610.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"798_CR66","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1038\/s41467-020-19821-7","volume":"11","author":"P Mancuso","year":"2020","unstructured":"Mancuso P, Chen C, Kaminski R, Gordon J, Liao S, Robinson JA, Smith MD, Liu H, Sariyer IK, Sariyer R, et al. CRISPR based editing of SIV proviral DNA in ART treated non-human primates. Nat Commun. 2020;11:6065.","journal-title":"Nat Commun"},{"key":"798_CR67","doi-asserted-by":"publisher","first-page":"103063","DOI":"10.1016\/j.omtn.2026.103063","volume":"37","author":"H Liu","year":"2026","unstructured":"Liu H, Liao S, Chen C, Huo W, Safaei Z, Rocchi A, Huang Y, Sariyer IK, Collins ME, Lawrence JM, et al. In vivo genome editing of central nervous system SIV reservoirs in ART-suppressed rhesus macaques. Mol Therapy Nucleic Acids. 2026;37:103063.","journal-title":"Mol Therapy Nucleic Acids"},{"key":"798_CR68","doi-asserted-by":"publisher","first-page":"e2217887120","DOI":"10.1073\/pnas.2217887120","volume":"120","author":"PK Dash","year":"2023","unstructured":"Dash PK, Chen C, Kaminski R, Su H, Mancuso P, Sillman B, Zhang C, Liao S, Sravanam S, Liu H, et al. CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice. Proc Natl Acad Sci U S A. 2023;120:e2217887120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"798_CR69","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMoa2601608","volume":"394","author":"RC Ahrens-Nicklas","year":"2026","unstructured":"Ahrens-Nicklas RC, Kotch C, Roche AM, Everett JK, Reddy S, Santi M, Madsen PJ, Martos-Rus C, Yrigollen CM, Small JC, et al. Neuroepithelial Tumor with AAV Integration after Intracisternal Magna Vector Delivery. N Engl J Med. 2026;394:2126\u201333.","journal-title":"N Engl J Med"},{"key":"798_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","volume":"25","author":"D Goertsen","year":"2022","unstructured":"Goertsen D, Flytzanis NC, Goeden N, Chuapoco MR, Cummins A, Chen Y, Fan Y, Zhang Q, Sharma J, Duan Y, et al. AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset. Nat Neurosci. 2022;25:106\u201315.","journal-title":"Nat Neurosci"},{"key":"798_CR71","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1038\/ncomms10844","volume":"7","author":"T Bruel","year":"2016","unstructured":"Bruel T, Guivel-Benhassine F, Amraoui S, Malbec M, Richard L, Bourdic K, Donahue DA, Lorin V, Casartelli N, No\u00ebl N, et al. Elimination of HIV-1-infected cells by broadly neutralizing antibodies. Nat Commun. 2016;7:10844.","journal-title":"Nat Commun"},{"key":"798_CR72","doi-asserted-by":"publisher","first-page":"eadv5572","DOI":"10.1126\/science.adv5572","volume":"389","author":"TG Caniels","year":"2025","unstructured":"Caniels TG, Prabhakaran M, Ozorowski G, MacPhee KJ, Wu W, van der Straten K, Agrawal S, Derking R, Reiss E, Millard K, et al. Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science. 2025;389:eadv5572.","journal-title":"Science"},{"key":"798_CR73","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41467-022-28307-7","volume":"13","author":"J Dufloo","year":"2022","unstructured":"Dufloo J, Planchais C, Fr\u00e9mont S, Lorin V, Guivel-Benhassine F, Stefic K, Casartelli N, Echard A, Roingeard P, Mouquet H, et al. Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells. Nat Commun. 2022;13:630.","journal-title":"Nat Commun"},{"key":"798_CR74","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1172\/JCI135557","volume":"130","author":"M Tuyishime","year":"2020","unstructured":"Tuyishime M, Garrido C, Jha S, Moeser M, Mielke D, LaBranche C, Montefiori D, Haynes BF, Joseph S, Margolis DM, et al. Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies. J Clin Investig. 2020;130:5157\u201370.","journal-title":"J Clin Investig"},{"key":"798_CR75","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/QAD.0b013e32834507bd","volume":"25","author":"D Tudor","year":"2011","unstructured":"Tudor D, Bomsel M. The broadly neutralizing HIV-1 IgG 2F5 elicits gp41-specific antibody-dependent cell cytotoxicity in a Fc\u03b3RI-dependent manner. AIDS. 2011;25:751\u20139.","journal-title":"AIDS"},{"key":"798_CR76","doi-asserted-by":"publisher","first-page":"106015","DOI":"10.1016\/j.antiviral.2024.106015","volume":"231","author":"AI Schriek","year":"2024","unstructured":"Schriek AI, Falck D, Wuhrer M, Kootstra NA, van Gils MJ, de Taeye SW. Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions. Antiviral Res. 2024;231:106015.","journal-title":"Antiviral Res"},{"key":"798_CR77","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s42003-024-06659-8","volume":"7","author":"SW de Taeye","year":"2024","unstructured":"de Taeye SW, Schriek AI, Umotoy JC, Grobben M, Burger JA, Sanders RW, Vidarsson G, Wuhrer M, Falck D, Kootstra NA, et al. Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing. Commun Biol. 2024;7:964.","journal-title":"Commun Biol"},{"key":"798_CR78","doi-asserted-by":"publisher","first-page":"e1012665","DOI":"10.1371\/journal.ppat.1012665","volume":"20","author":"BJ Snow","year":"2024","unstructured":"Snow BJ, Keles NK, Grunst MW, Janaka SK, Behrens RT, Evans DT. Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells. PLoS Pathog. 2024;20:e1012665.","journal-title":"PLoS Pathog"},{"key":"798_CR79","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nm.4063","volume":"22","author":"AJ Hessell","year":"2016","unstructured":"Hessell AJ, Jaworski JP, Epson E, Matsuda K, Pandey S, Kahl C, Reed J, Sutton WF, Hammond KB, Cheever TA, et al. Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques. Nat Med. 2016;22:362\u20138.","journal-title":"Nat Med"},{"key":"798_CR80","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/QAD.0b013e3283437d2f","volume":"25","author":"A Nath","year":"2011","unstructured":"Nath A, Clements J. Eradication of HIV from the brain: reasons for pause. AIDS. 2011;25:577\u201380.","journal-title":"AIDS"},{"key":"798_CR81","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1158\/2159-8290.CD-20-1661","volume":"11","author":"D Alizadeh","year":"2021","unstructured":"Alizadeh D, Wong RA, Gholamin S, Maker M, Aftabizadeh M, Yang X, Pecoraro JR, Jeppson JD, Wang D, Aguilar B, et al. IFN\u03b3 Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity. Cancer Discov. 2021;11:2248\u201365.","journal-title":"Cancer Discov"},{"key":"798_CR82","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/jnen\/nlx115","volume":"77","author":"AC Knight","year":"2018","unstructured":"Knight AC, Brill SA, Queen SE, Tarwater PM, Mankowski JL. Increased Microglial CSF1R Expression in the SIV\/Macaque Model of HIV CNS Disease. J Neuropathol Exp Neurol. 2018;77:199\u2013206.","journal-title":"J Neuropathol Exp Neurol"},{"key":"798_CR83","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/brain\/awae153","volume":"147","author":"DG Bohannon","year":"2024","unstructured":"Bohannon DG, Zablocki-Thomas LD, Leung ES, Dupont JK, Hattler JB, Kowalewska J, Zhao M, Luo J, Salemi M, Amedee AM, et al. CSF1R inhibition depletes brain macrophages and reduces brain virus burden in SIV-infected macaques. Brain. 2024;147:3059\u201369.","journal-title":"Brain"},{"key":"798_CR84","doi-asserted-by":"publisher","first-page":"001858","DOI":"10.1099\/jgv.0.001858","volume":"104","author":"GR Campbell","year":"2023","unstructured":"Campbell GR, Rawat P, Teodorof-Diedrich C, Spector SA. IRAK1 inhibition blocks the HIV-1 RNA mediated pro-inflammatory cytokine response from microglia. J Gen Virol. 2023;104:001858.","journal-title":"J Gen Virol"},{"key":"798_CR85","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12974-019-1466-8","volume":"16","author":"F Zhou","year":"2019","unstructured":"Zhou F, Liu X, Gao L, Zhou X, Cao Q, Niu L, Wang J, Zuo D, Li X, Yang Y, et al. HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K\/Akt and ERK MAPK pathways. J Neuroinflammation. 2019;16:71.","journal-title":"J Neuroinflammation"},{"key":"798_CR86","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.jcbfm.9600330","volume":"27","author":"GD Kanmogne","year":"2007","unstructured":"Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab. 2007;27:123\u201334.","journal-title":"J Cereb Blood Flow Metab"},{"key":"798_CR87","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1096\/fj.08-121624","volume":"23","author":"W Huang","year":"2009","unstructured":"Huang W, Eum SY, Andr\u00e1s IE, Hennig B, Toborek M. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. Faseb j. 2009;23:1596\u2013606.","journal-title":"Faseb j"},{"key":"798_CR88","doi-asserted-by":"publisher","first-page":"e0151702","DOI":"10.1371\/journal.pone.0151702","volume":"11","author":"LD Jones","year":"2016","unstructured":"Jones LD, Jackson JW, Maggirwar SB. Modeling HIV-1 Induced neuroinflammation in mice: role of platelets in mediating blood-brain barrier dysfunction. PLoS ONE. 2016;11:e0151702.","journal-title":"PLoS ONE"},{"key":"798_CR89","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nano.2013.06.012","volume":"10","author":"T Gerson","year":"2014","unstructured":"Gerson T, Makarov E, Senanayake TH, Gorantla S, Poluektova LY, Vinogradov SV. Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain. Nanomedicine. 2014;10:177\u201385.","journal-title":"Nanomedicine"},{"key":"798_CR90","doi-asserted-by":"publisher","first-page":"e00924","DOI":"10.1128\/JVI.00924-20","volume":"94","author":"C Teodorof-Diedrich","year":"2020","unstructured":"Teodorof-Diedrich C, Spector SA. Human immunodeficiency virus type 1 and methamphetamine-mediated mitochondrial damage and neuronal degeneration in human neurons. J Virol. 2020;94:e00924-20.","journal-title":"J Virol"},{"key":"798_CR91","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11481-012-9364-1","volume":"7","author":"C Tian","year":"2012","unstructured":"Tian C, Sun L, Jia B, Ma K, Curthoys N, Ding J, Zheng J. Mitochondrial glutaminase release contributes to glutamate-mediated neurotoxicity during human immunodeficiency virus-1 infection. J Neuroimmune Pharmacol. 2012;7:619\u201328.","journal-title":"J Neuroimmune Pharmacol"},{"key":"798_CR92","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.4049\/jimmunol.1101868","volume":"187","author":"SA Cross","year":"2011","unstructured":"Cross SA, Cook DR, Chi AW, Vance PJ, Kolson LL, Wong BJ, Jordan-Sciutto KL, Kolson DL. Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection. J Immunol. 2011;187:5015\u201325.","journal-title":"J Immunol"},{"key":"798_CR93","doi-asserted-by":"publisher","first-page":"15741","DOI":"10.1021\/acsnano.0c09553","volume":"15","author":"B Surnar","year":"2021","unstructured":"Surnar B, Shah AS, Park M, Kalathil AA, Kamran MZ, Ramirez Jaime R, Toborek M, Nair M, Kolishetti N, Dhar S. Brain-accumulating nanoparticles for assisting astrocytes to reduce human immunodeficiency virus and drug abuse-induced neuroinflammation and oxidative stress. ACS Nano. 2021;15:15741\u201353.","journal-title":"ACS Nano"},{"key":"798_CR94","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1212\/WNL.0b013e3181bd10e7","volume":"73","author":"JT Becker","year":"2009","unstructured":"Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher BR. Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology. 2009;73:1292\u20139.","journal-title":"Neurology"},{"key":"798_CR95","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/infdis\/jis326","volume":"206","author":"V Valcour","year":"2012","unstructured":"Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D, Suwanwela NC, Jagodzinski L, Michael N, Spudich S, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis. 2012;206:275\u201382.","journal-title":"J Infect Dis"},{"key":"798_CR96","doi-asserted-by":"publisher","first-page":"e1010105","DOI":"10.1371\/journal.ppat.1010105","volume":"17","author":"V Sharma","year":"2021","unstructured":"Sharma V, Creegan M, Tokarev A, Hsu D, Slike BM, Sacdalan C, Chan P, Spudich S, Ananworanich J, Eller MA, et al. Cerebrospinal fluid CD4\u2009+\u2009T cell infection in humans and macaques during acute HIV-1 and SHIV infection. PLoS Pathog. 2021;17:e1010105.","journal-title":"PLoS Pathog"},{"key":"798_CR97","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1093\/infdis\/jiz030","volume":"220","author":"J Hellmuth","year":"2019","unstructured":"Hellmuth J, Slike BM, Sacdalan C, Best J, Kroon E, Phanuphak N, Fletcher JLK, Prueksakaew P, Jagodzinski LL, Valcour V, et al. Very early initiation of antiretroviral therapy during acute HIV infection is associated with normalized levels of immune activation markers in cerebrospinal fluid but not in plasma. J Infect Dis. 2019;220:1885\u201391.","journal-title":"J Infect Dis"},{"key":"798_CR98","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/infdis\/jix662","volume":"217","author":"PD Burbelo","year":"2018","unstructured":"Burbelo PD, Price RW, Hagberg L, Hatano H, Spudich S, Deeks SG, Gissl\u00e9n M. Anti-human immunodeficiency virus antibodies in the cerebrospinal fluid: evidence of early treatment impact on central nervous system reservoir? J Infect Dis. 2018;217:1024\u201332.","journal-title":"J Infect Dis"},{"key":"798_CR99","doi-asserted-by":"publisher","first-page":"e1011290","DOI":"10.1371\/journal.ppat.1011290","volume":"19","author":"SJ Byrnes","year":"2023","unstructured":"Byrnes SJ, Busman-Sahay K, Angelovich TA, Younger S, Taylor-Brill S, Nekorchuk M, Bondoc S, Dannay R, Terry M, Cochrane CR, et al. Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques. PLoS Pathog. 2023;19:e1011290.","journal-title":"PLoS Pathog"},{"key":"798_CR100","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41593-021-00802-y","volume":"24","author":"A Gordon","year":"2021","unstructured":"Gordon A, Yoon SJ, Tran SS, Makinson CD, Park JY, Andersen J, Valencia AM, Horvath S, Xiao X, Huguenard JR, et al. Long-term maturation of human cortical organoids matches key early postnatal transitions. Nat Neurosci. 2021;24:331\u201342.","journal-title":"Nat Neurosci"},{"key":"798_CR101","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s13365-024-01204-z","volume":"30","author":"M Donadoni","year":"2024","unstructured":"Donadoni M, Cakir S, Bellizzi A, Swingler M, Sariyer IK. Modeling HIV-1 infection and NeuroHIV in hiPSCs-derived cerebral organoid cultures. J Neurovirol. 2024;30:362\u201379.","journal-title":"J Neurovirol"},{"key":"798_CR102","doi-asserted-by":"crossref","unstructured":"dos Reis RS, Sant S, Ayyavoo V. Three-dimensional human brain organoids to model HIV-1 neuropathogenesis. In: Aquino de Muro M, editor. Virus-Host Interactions: Methods and Protocols. Springer US; 2023;2610:167\u201378.","DOI":"10.1007\/978-1-0716-2895-9_14"},{"key":"798_CR103","doi-asserted-by":"publisher","first-page":"1351734","DOI":"10.3389\/fncel.2024.1351734","volume":"18","author":"HH Zhao","year":"2024","unstructured":"Zhao HH, Haddad G. Brain organoid protocols and limitations. Front Cell Neurosci. 2024;18:1351734.","journal-title":"Front Cell Neurosci"},{"key":"798_CR104","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41586-026-10877-x","volume":"657","author":"I Faravelli","year":"2026","unstructured":"Faravelli I, Ant\u00f3n-Bola\u00f1os N, Wei A, Faits T, Kumar AS, Andreadis S, Kastli R, Crespo MM, Steiger M, Leible D, et al. Human brain organoids record the passage of time over multiple years. Nature. 2026;657:713\u201323.","journal-title":"Nature"},{"key":"798_CR105","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/cells13131127","volume":"13","author":"R Van Duyne","year":"2024","unstructured":"Van Duyne R, Irollo E, Lin A, Johnson JA, Guillem AM, O\u2019Brien EV, Merja L, Nash B, Jackson JG, Sarkar A, et al. Adult human brain tissue cultures to study neuroHIV. Cells. 2024;13:1127.","journal-title":"Cells"},{"key":"798_CR106","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/v14091997","volume":"14","author":"SJ Byrnes","year":"2022","unstructured":"Byrnes SJ, Angelovich TA, Busman-Sahay K, Cochrane CR, Roche M, Estes JD, Churchill MJ. Non-human primate models of HIV brain infection and cognitive disorders. Viruses. 2022;14:1997.","journal-title":"Viruses"},{"key":"798_CR107","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.4411","volume":"23","author":"JD Estes","year":"2017","unstructured":"Estes JD, Kityo C, Ssali F, Swainson L, Makamdop KN, Del Prete GQ, Deeks SG, Luciw PA, Chipman JG, Beilman GJ, et al. Defining total-body AIDS-virus burden with implications for curative strategies. Nat Med. 2017;23:1271\u20136.","journal-title":"Nat Med"},{"key":"798_CR108","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/mp.2015.111","volume":"21","author":"LR Gray","year":"2016","unstructured":"Gray LR, Cowley D, Welsh C, Lu HK, Brew BJ, Lewin SR, Wesselingh SL, Gorry PR, Churchill MJ. CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies. Mol Psychiatry. 2016;21:574\u201384.","journal-title":"Mol Psychiatry"},{"key":"798_CR109","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/cid\/ciy1066","volume":"69","author":"SB Joseph","year":"2019","unstructured":"Joseph SB, Kincer LP, Bowman NM, Evans C, Vinikoor MJ, Lippincott CK, Gissl\u00e9n M, Spudich S, Menezes P, Robertson K, et al. Human immunodeficiency virus type 1 RNA detected in the central nervous system (CNS) after years of suppressive antiretroviral therapy can originate from a replicating CNS reservoir or clonally expanded cells. Clin Infect diseases: official publication Infect Dis Soc Am. 2019;69:1345\u201352.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00798-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-026-00798-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00798-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:02:24Z","timestamp":1792274544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-026-00798-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1007\/s11904-026-00798-9","relation":{},"ISSN":["1548-3576"],"issn-type":[{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"3 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have contributed to this article and reviewed and approved the final version of the manuscript for publication.","order":1,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","label":"Human and Animal Rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Generative AI was not used in the preparation of the manuscript.","order":4,"name":"Ethics","label":"AI Usage","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29"}}